Urovant Sciences Competitors and Similar CompaniesClear all

Urovant Sciences's competitors and similar companies include Astellas Pharma and Kymera Therapeutics.

	Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.	Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.	Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Founding Date	Founding Date 2016	Founding Date 1923	Founding Date 2017
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare diabetes drug development oncology pharma	Tags Healthcare biotech drug development therapy
Locations	Locations Irvine, US HQ Basel, CH	Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more	Locations Watertown, US HQ Cambridge, US
Employees	Employees 3950% increase	Employees 14,754	Employees 207
Valuation ($)	Valuation ($) N/A	Valuation ($) 20.8 b	Valuation ($) 3.1 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥2.1t (FY, 2026)	Revenue (est.) $39.2m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥213.8b (FY, 2026)	Cost of goods $39.2m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ¥2t (FY, 2026)	Gross profit N/A
Net income	Net income ($146.7m) (FY, 2020)	Net income ¥291.6b (FY, 2026)	Net income ($311.4m) (FY, 2025)